The global Fibrotic Diseases Treatment Market has witnessed substantial growth in recent years due to rising prevalence of chronic fibrotic conditions such as idiopathic pulmonary fibrosis (IPF), hepatic fibrosis, and renal fibrosis. These diseases, characterized by excessive deposition of extracellular matrix components, lead to organ dysfunction, scarring, and, in severe cases, failure....
Portuguese (Brazil)
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek